Parameters | Total population (n = 122) | Non-MVO group (n = 71) | MVO group (n = 51) | p-value |
---|---|---|---|---|
Age (years) | 60.6 ± 12.8 | 61.1 ± 14.1 | 59.8 ± 10.9 | 0.593 |
Male, n (%) | 88 (72.1) | 49 (69.0) | 39 (76.5) | 0.365 |
Heart rate (bpm) | 79.8 ± 13.7 | 76.8 ± 12.9 | 82.9 ± 18.5 | 0.154 |
Systolic blood pressure (mmHg) | 133.5 ± 20.7 | 133.0 ± 23.9 | 134.2 ± 15.5 | 0.733 |
Diastolic blood pressure (mmHg) | 81.6 ± 14.1 | 80.6 ± 14.7 | 83.0 ± 13.2 | 0.345 |
Hypertension, n (%) | 58 (47.5) | 36 (50.7) | 22 (43.1) | 0.409 |
Diabetes, n (%) | 32 (26.2) | 17 (23.9) | 15 (29.4) | 0.498 |
Current Smoker, n (%) | 27 (22.1) | 13 (18.3) | 14 (27.5) | 0.230 |
Dyslipidemia, n (%) | 16 (13.1) | 10 (14.1) | 6 (11.8) | 0.708 |
GRACE score, n (%) | 141.8 ± 29.0 | 133.2 ± 23.9 | 140.1 ± 31.2 | 0.188 |
Peak Troponin I (ng/ml) | 23.7 (13.7 to 30.0) | 15.8 (9.8 to 28.6) | 30.0 (23.7 to 30.0) |  < 0.001 |
Peak CK (U/L) | 2748.5 (1432.5 to 3817.5) | 1925.5 (1138.5 to 3053.0) | 3505.0 (2708.5 to 6920.3) |  < 0.001 |
Peak CK-MB (U/L) | 270.0 (202.0 to 404.0) | 211.0 (163.0 to 276.0) | 346.0 (274.0 to 473.0) |  < 0.001 |
PRO-BNP (pg/mL) | 815.0 (432.5 to 1996.5) | 683.5 (427.8 to 933.0) | 987.0 (515.8 to 3205.3) | 0.026 |
CRP (mg/L) | 6.9 (3.2 to 17.1) | 4.8 (3.0 to 13.5) | 9.9 (4.2 to 25.9) | 0.008 |
Serum creatinine (umol/L) | 58.6 (49.9 to 75.6) | 58.4 (48.7 to 72.0) | 58.9 (52.0 to 79.8) | 0.144 |
Serum uric acid (umol/L) | 301.2 (242.2 to 383.1) | 291.6 (236.1 to 362.6) | 307.8 (244.9 to 405.5) | 0.234 |
Albumin (g/L) | 37.3 ± 4.3 | 37.1 ± 4.4 | 37.6 ± 4.0 | 0.592 |
Plasma fibrinogen (g/L) | 2.6 ± 1.0 | 2.6 ± 1.0 | 2.6 ± 0.9 | 0.882 |
D-Dimer (ng/ml) | 89.7 (67.4 to 154.5) | 84.7 (67.5 to 125.0) | 99.0 (67.1 to 187.0) | 0.075 |
Neutrophil (× 109/L) | 7.9 (6.3 to 10.3) | 7.9 (6.1 to 9.8) | 8.5 (6.3 to 10.7) | 0.165 |
Lymphocyte (× 109/L) | 1.3 (0.9 to 1.6) | 1.2 (0.9 to 1.6) | 1.3 (1.0 to 1.5) | 0.682 |
Total cholesterol (mmol/L) | 4.1 (3.6 to 4.8) | 4.2 (3.6 to 4.8) | 3.9 (3.5 to 4.9) | 0.267 |
Triglyceride (mmol/L) | 1.2 (0.8 to 1.6) | 1.1 (0.8 to 1.6) | 1.4 (0.9 to 1.7) | 0.075 |
LDL-C (mmol/L) | 2.5 ± 0.6 | 2.5 ± 0.7 | 2.5 ± 0.5 | 0.458 |
HDL-C (mmol/L) | 1.2 (1.0 to 1.6) | 1.2 (1.0 to 1.6) | 1.2 (1.0 to 1.5) | 0.769 |
Heart failure Killip class, n (%) | ||||
I | 91 (74.6) | 55 (77.5) | 36 (70.6) | 0.389 |
 ≥ II | 31 (15.4) | 16 (12.5) | 15 (29.4) |  |
Time from symptom onset to PCI (h) | 6.2 (4.5 to 9.3) | 6.0 (5.0 to 9.0) | 6.2 (4.0 to 11.3) | 0.545 |
Culprit artery, n (%) | ||||
LAD | 66 (54.1) | 28 (39.4) | 38 (74.5) |  < 0.001 |
LCX | 9 (7.4) | 6 (8.5) | 3 (5.9) | 0.592 |
RCA | 47 (38.5) | 37 (52.1) | 10 (19.6) |  < 0.001 |
Number of diseased arteries, n (%) | ||||
Single-artery | 64 (52.5) | 34 (47.9) | 30 (58.8) | 0.233 |
Multi-artery | 58 (47.5) | 37 (42.1) | 21 (41.2) | Â |
Initial TIMI flow grade, n (%) | ||||
0/1 | 95 (77.9) | 48 (67.6) | 47 (92.2) | 0.001 |
2/3 | 27 (67.6) | 23 (32.4) | 4 (7.8) | Â |
Final TIMI flow grade, n (%) | ||||
0/1 | 112 (91.8) | 67 (94.4) | 45 (88.2) | 0.223 |
2/3 | 10 (8.2) | 4 (5.6) | 6 (11.8) | Â |
Time from PCI to CMR (days) | 5.2 (4.3 to 6.4) | 5.1 (3.8 to 6.2) | 5.2 (4.5 to 6.9) | 0.275 |
LVEF (%) | 36.7 ± 10.2 | 40.7 ± 9.7 | 31.2 ± 8.4 |  < 0.001 |
AAR (% LV) | 28.3 (22.5 to 34.8) | 25.3 (20.4 to 29.3) | 34.8 (28.2 to 37.8) |  < 0.001 |
IS (% LV) | 22.3 (15.6 to 32.5) | 18.4 (13.2 to 22.3) | 27.3 (23.8 to 33.1) |  < 0.001 |
MSI (%) | 22.3 (13.9 to 37.2) | 25.7 (14.9 to 44.8) | 16.3 (8.8 to 22.2) |  < 0.001 |
SYNTAX score | 17.8 (11.0 to 22.0) | 16.0 (10.0 to 18.0) | 20.0 (15.8 to 22.3) |  < 0.001 |
SYNTAX II score | 33.6 ± 10.0 | 29.8 ± 8.8 | 38.8 ± 9.2 |  < 0.001 |
Gensini score | 53.0 (36.0 to 80.0) | 44.0 (32.0 to 58.0) | 74.0 (50.5 to 81.5) |  < 0.001 |